Rising Protectionism And Regulatory Burdens Will Undermine Pharma Exports
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 29 Analysts
Published
13 Jun 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
₹4,652.59
31.8% overvalued intrinsic discount09 Aug
₹6,132.50
1Y
31.5%7D
0.02%